Aurobindo Pharma has informed that S. Subramanian, Chief Financial Officer of the Company, will be participating in group investors conference (virtual) arranged by SNP Pari bas on 20th June 2022 at 13:30-14:20 hrs IST. No unpublished price sensitive information (UPSI) is intended to be discussed during the conference. This information is submitted pursuant to Regulation 30(6) of the Listing Regulations. The changes may happen in the schedule of the aforesaid conference due to exigencies on the part of Participants / Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.85 |
| Dr. Reddys Lab | 1236.40 |
| Cipla | 1233.10 |
| Zydus Lifesciences | 937.40 |
| Lupin | 2329.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: